{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:15:37Z","timestamp":1794946537868,"version":"4.9.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00209","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:26:01Z","timestamp":1583414761000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity"],"prefix":"10.3389","volume":"11","author":[{"given":"Pushpendra","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther N.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Ionova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele K.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Karakantza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Al-Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Langton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"B1","year":"2018","journal-title":"Blood Cancers [Online]."},{"key":"B2","year":"2019","journal-title":"Side Effects of Chemotherapy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jval.2012.08.2210","article-title":"Measuring health-related quality of life in leukemia: the functional assessment of cancer therapy\u2013Leukemia (FACT-Leu) questionnaire.","volume":"15","author":"Cella","year":"2012","journal-title":"Value Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","article-title":"An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.","volume":"43","author":"Cocks","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"B5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1023254226592","article-title":"Pretesting survey instruments: an overview of cognitive methods.","volume":"12","author":"Collins","year":"2003","journal-title":"Qual. Life Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ejh.12864","article-title":"The Myeloma patient outcome scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.","volume":"98","author":"Davies","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"B7","year":"2017","journal-title":"Haematological Malignancy Research Network Incidence &amp; Survival [Online]."},{"key":"B8","author":"DeVellis","year":"2016","journal-title":"Scale Development: Theory and Applications."},{"key":"B9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11136-013-0523-525","article-title":"International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.","volume":"23","author":"Efficace","year":"2014","journal-title":"Qual. Life Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00277-014-2290-y","article-title":"Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.","volume":"94","author":"Espinoza-Zamora","year":"2015","journal-title":"Ann. Hematol."},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511518201","author":"Foddy","year":"1993","journal-title":"Constructing Questions for Interviews and Questionnaires."},{"key":"B12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ejh.13203","article-title":"Haematological malignancy: are we measuring what is important to patients? A systematic review of quality-of-life instruments.","volume":"102","author":"Goswami","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v128.22.5985.5985","article-title":"Development of a Novel Patient-reported outcome measure in haematological malignancy for use in routine clinical practice: item generation.","volume":"128","author":"Goswami","year":"2016","journal-title":"Blood"},{"key":"B14","first-page":"2176","article-title":"HM-PRO: a novel patient-reported outcome measure in hematological malignancy for use in clinical practice.","volume":"130","author":"Goswami","year":"2017","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(sici)1098-240x(199706)20:3<269::aid-nur9>3.0.co;2-g","article-title":"Selection and use of content experts for instrument development.","volume":"20","author":"Grant","year":"1997","journal-title":"Res. Nurs. Health"},{"key":"B16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life.","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/16506073.2014.972443","article-title":"Content validity in psychological assessment: a functional approach to concepts and methods.","volume":"7","author":"Haynes","year":"1995","journal-title":"Psychol. Assess."},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1600-0609.2004.00233.x","article-title":"Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.","volume":"72","author":"Holzner","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","article-title":"Health related quality of life in a nationally representative sample of haematological patients.","volume":"83","author":"Johnsen","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-13","article-title":"Validation of the M. D. Anderson Symptom Inventory multiple myeloma module.","volume":"6","author":"Jones","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.ccr-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms.","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/842867","article-title":"Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.","volume":"2012","author":"Kontodimopoulos","year":"2012","journal-title":"Sci. World J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research.","volume":"15","author":"Koo","year":"2016","journal-title":"J. Chiropract. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1744-6570.1975.tb01393.x","article-title":"A quantitative approach to content validity.","volume":"28","author":"Lawshe","year":"1975","journal-title":"Person. Psychol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1524-4733.1999.02210.x","article-title":"Recommendations for evaluating the validity of quality of life claims for labeling and promotion.","volume":"2","author":"Leidy","year":"1999","journal-title":"Value Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/s0897-1897(05)80008-4","article-title":"Instrument review: getting the most from a panel. (of)experts.","volume":"5","author":"LindseyDavis","year":"1992","journal-title":"Appl. Nurs. Res."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-008-9413-7","article-title":"Using patient-reported outcomes in clinical practice: challenges and opportunities.","volume":"18","author":"Lohr","year":"2008","journal-title":"Qual. Life Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1188\/12.ONF.595-600","article-title":"The impact on sexuality after diagnosis and treatment for a hematologic malignancy: findings from Australia.","volume":"39","author":"McGrath","year":"2012","journal-title":"Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/cncr.22581","article-title":"Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study.","volume":"109","author":"Mols","year":"2007","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s11136-011-0003-8","article-title":"Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.","volume":"21","author":"Norquist","year":"2012","journal-title":"Qual. Life Res."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1261-1266","article-title":"Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS).","volume":"15","author":"Osborne","year":"2015","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2013assessing respondent understanding.","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1046\/j.1365-2354.2001.00236.x","article-title":"Acute leukaemia or highly malignant lymphoma patients\u2019 quality of life over two years: a pilot study.","volume":"10","author":"Persson","year":"2001","journal-title":"Eu. J. Cancer Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/nur.20147","article-title":"The content validity index: are you sure you know what\u2019s being reported? Critique and recommendations.","volume":"29","author":"Polit","year":"2006","journal-title":"Res. Nurs. Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpsychores.2005.08.017","article-title":"Psychosocial adaptation and quality of life among Brazilian patients with different hematological malignancies.","volume":"60","author":"Santos","year":"2006","journal-title":"J. Psychosom. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06791.x","article-title":"Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.","volume":"139","author":"Shanafelt","year":"2007","journal-title":"Br. J. Haematol."},{"key":"B37","first-page":"152","article-title":"Content validity index in scale development.","volume":"37","author":"Shi","year":"2012","journal-title":"Zhong nan da xue xue bao. Yi xue ban J. Central South Univ. Med. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01206.x","article-title":"Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and treatment of cancer study group on quality of life.","volume":"104","author":"Stead","year":"1999","journal-title":"Br. J. Haematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-0609.2008.01126.x","article-title":"Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.","volume":"81","author":"Strasser-Weippl","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198528470.001.0001","author":"Streiner","year":"2003","journal-title":"Heatlh Measurement Scales a Practical Guide to Their Development and Use."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-017-0757-y","article-title":"Proceedings of patient reported outcome Measure\u2019s (PROMs) conference Oxford 2017: advances in patient reported outcomes research.","volume":"15","author":"Velikova","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"B42","year":"2017","journal-title":"Cancer: Diagnosis and Treatment [Online]."},{"key":"B43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/0193945903252998","article-title":"Two quantitative approaches for estimating content validity.","volume":"25","author":"Wynd","year":"2003","journal-title":"West J. Nurs. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15171\/jcs.2015.017","article-title":"Design and implementation content validity study: development of an instrument for measuring patient-centered communication.","volume":"4","author":"Zamanzadeh","year":"2015","journal-title":"J. Caring Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T17:13:20Z","timestamp":1722532400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":44,"alternative-id":["10.3389\/fphar.2020.00209"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00209","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fphar.2020.00209.s001","asserted-by":"subject"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"article-number":"209"}}